Literature DB >> 20692822

Short-term weight loss in overweight/obese low-income women improves plasma zinc and metabolic syndrome risk factors.

Venkata Saroja Voruganti1, Guowen Cai, Deborah M Klohe, Kristine C Jordan, Michelle A Lane, Jeanne H Freeland-Graves.   

Abstract

Metabolic syndrome is a group of disorders involving obesity, insulin resistance, dyslipidemia and hypertension. Obesity is the most crucial risk factor of metabolic syndrome, because it is known to precede other risk factors. Obesity is also associated with disturbances in the metabolism of the trace mineral, zinc. The overall purpose of this study was to investigate the effects of short-term weight loss on plasma zinc and metabolic syndrome risk factors. An 8-week weight loss intervention study was conducted with 90 low-income overweight/obese mothers, whose youngest child was 1-3 years old. Plasma levels of zinc, glucose, insulin, leptin, triglycerides, total, high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol were measured and compared at weeks 0 and 8 of the weight loss program. At pre-study, plasma zinc was low in 39% and, within normal values in 46%, of obese/overweight mothers. By the end of intervention, plasma zinc rose by 22% and only 5% of the mothers continued to exhibit low plasma zinc. At post-study, the metabolic syndrome risk factors of waist circumference, HDL cholesterol, and diastolic blood pressure (p<0.05) showed significant improvements. Plasma zinc increased by a greater margin (67%) in women with low zinc, as compared to those with normal zinc (18%); weight reduction was similar in both the groups. Finally, changes in % body fat were related negatively with changes in plasma zinc (r=- 0.28, p<0.05). The circulating levels of zinc, as well as the metabolic syndrome components, showed significant improvements in overweight/obese low-income women after weight loss.
Copyright © 2010 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20692822     DOI: 10.1016/j.jtemb.2010.05.001

Source DB:  PubMed          Journal:  J Trace Elem Med Biol        ISSN: 0946-672X            Impact factor:   3.849


  7 in total

1.  Zinc deficiency augments leptin production and exacerbates macrophage infiltration into adipose tissue in mice fed a high-fat diet.

Authors:  Ming-Jie Liu; Shengying Bao; Eric R Bolin; Dara L Burris; Xiaohua Xu; Qinghua Sun; David W Killilea; Qiwen Shen; Ouliana Ziouzenkova; Martha A Belury; Mark L Failla; Daren L Knoell
Journal:  J Nutr       Date:  2013-05-22       Impact factor: 4.798

2.  Zinc.

Authors:  Anatoly V Skalny; Michael Aschner; Alexey A Tinkov
Journal:  Adv Food Nutr Res       Date:  2021-05-24

3.  Increased risk of iron deficiency and reduced iron absorption but no difference in zinc, vitamin A or B-vitamin status in obese women in India.

Authors:  Isabelle Herter-Aeberli; Prashanth Thankachan; Beena Bose; Anura V Kurpad
Journal:  Eur J Nutr       Date:  2015-10-10       Impact factor: 5.614

4.  Short-term effects of sibutramine on mineral status and selected biochemical parameters in obese women.

Authors:  Joanna Suliburska; Paweł Bogdański; Monika Szulińska; Danuta Pupek-Musialik
Journal:  Biol Trace Elem Res       Date:  2012-04-27       Impact factor: 3.738

5.  Gene expression of the zinc transporter ZIP14 (SLC39a14) is affected by weight loss and metabolic status and associates with PPARγ in human adipose tissue and 3T3-L1 pre-adipocytes.

Authors:  Trine Maxel; Kamille Smidt; Agnete Larsen; Marianne Bennetzen; Karina Cullberg; Karen Fjeldborg; Sten Lund; Steen B Pedersen; Jørgen Rungby
Journal:  BMC Obes       Date:  2015-11-24

Review 6.  Zinc and the Innovative Zinc-α2-Glycoprotein Adipokine Play an Important Role in Lipid Metabolism: A Critical Review.

Authors:  Michalina Banaszak; Ilona Górna; Juliusz Przysławski
Journal:  Nutrients       Date:  2021-06-11       Impact factor: 5.717

Review 7.  Zinc status is associated with inflammation, oxidative stress, lipid, and glucose metabolism.

Authors:  J Olechnowicz; A Tinkov; A Skalny; Joanna Suliburska
Journal:  J Physiol Sci       Date:  2017-09-30       Impact factor: 2.781

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.